HRMY
NASDAQ · Pharmaceuticals
Harmony Biosciences Holdings
$38.41
-0.34 (-0.88%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+1.27%
1Y
+10.37%
YTD
+2.76%
Open$39.20
Previous Close$38.75
Day High$39.43
Day Low$38.20
52W High$40.87
52W Low$25.52
Volume—
Avg Volume876.9K
Market Cap2.24B
P/E Ratio12.34
EPS$3.09
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$37.42
Above
SMA 200
$34.21
Above
RSI (14)
38.4
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
17 analysts
Price Target
+143.5% upside
Current
$38.41
$38.41
Target
$93.52
$93.52
$67.60
$93.52 avg
$113.52
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 932.07M | 741.86M | 502.35M |
| Net Income | 170.31M | 122.00M | 88.37M |
| Profit Margin | 18.3% | 17.4% | 17.6% |
| EBITDA | 249.33M | 188.53M | 150.20M |
| Free Cash Flow | — | — | 92.06M |
| Rev Growth | +25.6% | +25.6% | +14.6% |
| Debt/Equity | 0.19 | 0.19 | 0.38 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |